Abstract
Recent genetic studies have implicated an active role for intrahepatic lipid accumulation in the pathogenesis of both polycystic ovary syndrome (PCOS) and cardiovascular disease. These new insights may provide novel (non)pharmacological opportunities for the prevention and treatment of PCOS and cardiovascular disease at both the societal and clinical level.
| Original language | English |
|---|---|
| Pages (from-to) | 389-391 |
| Number of pages | 3 |
| Journal | Trends in Endocrinology and Metabolism |
| Volume | 36 |
| Issue number | 5 |
| Early online date | 1 Jan 2024 |
| DOIs | |
| Publication status | Published - May 2025 |
Keywords
- cardiovascular disease (CVD)
- fructose
- MASLD
- Mendelian randomization
- PCOS
- triangulation
Fingerprint
Dive into the research topics of 'Is cardiovascular disease in PCOS driven by MASLD?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver